Oct 20, 2020 | Brian Fargus, Caroline Fraker, MedBen employees, MedBen Rx, Pharmacogenomics, Specialty Drugs
MedBen Vice Presidents Caroline Fraker and Brian Fargus were among the featured speakers at the Sherrill-Morgan 7th Annual Healthcare Innovation Conference on Thursday, October 1. In her presentation, Senior Vice President Fraker discussed the potential problems of...
Sep 5, 2020 | Prescription drugs, Specialty Drugs
Myalept tops the list of the most expensive drugs currently sold in the United States, as compiled by GoodRx. Used to treat leptin deficiency, Myalept carries a list price of $71,306 for a 30-day prescription. Mavenclad, a multiple sclerosis treatment, follows at...
Feb 28, 2019 | Government, Legislation, MedBen Rx, Rx Costs, Rx Spending, Specialty Drugs
A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it’s why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As...
Dec 2, 2018 | Brand Name Drugs, Generic Drugs, MedBen Rx, MedBen Rx Advocate, MedBen Rx Alliance, Pharmacy Benefits Manager (PBM), Specialty Drugs
Modern Healthcare recently highlighted the growing disparity between brand-names and generics in relation to prescription drug spending. A new study finds that while total spending on generic drugs has declined, branded prescription drug spending continues to rise. In...
Nov 21, 2018 | MedBen Rx, Rebates, Rx Costs, Rx Spending, Savings, Specialty Drugs
A New York Times article examines the dramatic rise in U.S. prescription drug costs over the past two decades. American drug spending was once on par with other wealthy countries, but between 1997 and 2007 our drug spending tripled… and took off again in 2013....
